4.7 Article

No association between striatal dopamine transporter binding and body mass index: A multi-center European study in healthy volunteers

Journal

NEUROIMAGE
Volume 64, Issue -, Pages 61-67

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.neuroimage.2012.09.011

Keywords

Dopamine transporter; Striatum; Body mass index; Obesity; SPECT; [I-123]FP-CIT

Funding

  1. GE Healthcare
  2. German Parkinson Association

Ask authors/readers for more resources

Introduction: Dopamine is one among several neurotransmitters that regulate food intake and overeating. Thus, it has been linked to the pathophysiology of obesity and high body mass index (BM!). Striatal dopamine D-2 receptor availability is lower in obesity and there are indications that striatal dopamine transporter (DAT) availability is also decreased. In this study, we tested whether BMI and striatal DAT availability are associated. Methods: The study included 123 healthy individuals from a large European multi-center database. They had a BMI range of 18.2-41.1 kg/m(2) and were scanned using [I-123]FP-CIT SPECT imaging. Scans were analyzed with both region-of-interest and voxel-based analysis to determine the binding potential for DAT availability in the caudate nucleus and putamen. A direct relation between BMI and DAT availability was assessed and groups with high and low BMI were compared for DAT availability. Results: No association between BMI and striatal DAT availability was found. Conclusion: The lack of an association between BMI and striatal DAT availability suggests that the regulation of striatal synaptic dopamine levels by DAT plays no or a limited role in the pathophysiology of overweight and obesity. (C) 2012 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Neuronal underpinnings of cognitive impairment in bipolar disorder: A large data-driven functional magnetic resonance imaging study

Jeff Zarp Petersen, Cristina Varo, Cecilie F. Skovsen, Caroline V. Ott, Hanne L. Kjaerstad, Eduard Vieta, Catherine J. Harmer, Gitte M. Knudsen, Lars V. Kessing, Julian Macoveanu, Kamilla W. Miskowiak

Summary: Cognitive impairment in bipolar disorder originates from the failure to recruit key regions in the cognitive control network (CCN) and to suppress task-irrelevant default mode network (DMN) activity during cognitive performance.

BIPOLAR DISORDERS (2022)

Correction Radiology, Nuclear Medicine & Medical Imaging

EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3 (vol 49, pg 632, 2022)

Eric Guedj, Andrea Varrone, Ronald Boellaard, Nathalie L. Albert, Henryk Barthel, Bart van Berckel, Matthias Brendel, Diego Cecchin, Ozgul Ekmekcioglu, Valentina Garibotto, Adriaan A. Lammertsma, Ian Law, Ivan Penuelas, Franck Semah, Tatjana Traub-Weidinger, Elsmarieke van de Giessen, Donatienne Van Weehaeghe, Silvia Morbelli

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Reproducibility of 3 T APT-CEST in Healthy Volunteers and Patients With Brain Glioma

Ivar J. H. G. Wamelink, Joost P. A. Kuijer, Beatriz E. Padrela, Yi Zhang, Frederik Barkhof, Henk J. M. M. Mutsaerts, Jan Petr, Elsmarieke van de Giessen, Vera C. Keil

Summary: This study investigates the reproducibility of cerebral APT-CEST imaging in healthy tissue and gliomas at 3 T. The results indicate that cerebral APT-CEST shows good scan-rescan reproducibility in healthy tissue and tumors, and short-term measurement effects may be the dominant components for reproducibility.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Imaging Dopaminergic Neurotransmission in Neurodegenerative Disorders

Elon D. Wallert, Elsmarieke van de Giessen, Remco J. J. Knol, Martijn Beudel, Rob M. A. de Bie, Jan Booij

Summary: Imaging of dopaminergic transmission plays a crucial role in the diagnosis and research of neurodegenerative disorders. It provides high diagnostic accuracy in detecting nigrostriatal degeneration in diseases such as Parkinson's disease and dementia with Lewy bodies. Additionally, it helps in studying the preclinical and premotor phases of these disorders and examining different subtypes of Parkinson's disease. Imaging also aids in understanding the neuronal substrates of impulse control disorders and measuring endogenous dopamine release in the treatment of Parkinson's disease.

JOURNAL OF NUCLEAR MEDICINE (2022)

Review Neurosciences

Dopaminergic alterations in populations at increased risk for psychosis: A systematic review of imaging findings

Carmen F. M. van Hooijdonk, Marjan Drukker, Elsmarieke van de Giessen, Jan Booij, Jean-Paul Selten, Therese A. M. J. van Amelsvoort

Summary: Alterations in the dopaminergic system may play a role in vulnerability and transition to psychosis. Studies have shown that striatal dopamine D-2/3 receptor availability is generally unaltered in high-risk groups, while dopamine synthesis capacity varies among different high-risk groups.

PROGRESS IN NEUROBIOLOGY (2022)

Article Clinical Neurology

Acceleration of neuromelanin-sensitive MRI sequences in the substantia nigra using standard MRI options

Marieke van der Pluijm, Elon D. Wallert, Bram F. Coolen, Kaithlyn T. Tjong Tjin Joe, Lieuwe de Haan, Jan Booij, Elsmarieke van de Giessen

Summary: This study compared different approaches to accelerate NM-MRI sequences and found that 2D sequences with compressed sense (CS) had the best reliability.

NEURORADIOLOGY (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Comparison of [18F]-FDOPA PET and [123I]-FP-CIT SPECT acquired in clinical practice for assessing nigrostriatal degeneration in patients with a clinically uncertain parkinsonian syndrome

Elon Wallert, Erwann Letort, Friso van der Zant, Ania Winogrodzka, Henk Berendse, Martijn Beudel, Rob de Bie, Jan Booij, Pieter Raijmakers, Elsmarieke van de Giessen

Summary: This study compared the results of FDOPA-PET and DAT-SPECT in patients with parkinsonian syndromes and found that DAT-SPECT was more often abnormal than FDOPA-PET in early disease stages, indicating a greater loss of DAT binding in CUPS patients.

EJNMMI RESEARCH (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Tau pathology as determinant of changes in atrophy and cerebral blood flow: a multi-modal longitudinal imaging study

Denise Visser, Sander C. J. Verfaillie, Iris Bosch, Iman Brouwer, Hayel Tuncel, Emma M. Coomans, Roos M. Rikken, Sophie E. Mastenbroek, Sandeep S. V. Golla, Frederik Barkhof, Elsmarieke van de Giessen, Bart N. M. van Berckel, Wiesje M. van der Flier, Rik Ossenkoppele

Summary: The purpose of this study was to investigate the association between Tau pathology, atrophy, and cerebral blood flow (CBF) in Alzheimer's disease (AD). The results showed that increased Tau load was associated with cortical thinning, but not with decreased relative CBF. Baseline Tau PET load was a stronger predictor of cortical thinning than changes in Tau PET signal over time.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2023)

Review Clinical Neurology

The substantia nigra in the pathology of schizophrenia: A review on post-mortem and molecular imaging findings

Carmen F. M. van Hoojdonk, Marieke van der Pluijm, Iris Bosch, Therese A. M. J. van Amelsvoort, Jan Booij, Lieuwe de Haan, Jean-Paul Selten, Elsmarieke van de Giessen

Summary: This study reviewed different molecular aspects of nigral functioning in patients with schizophrenia compared to healthy controls and found evidence for hyperdopaminergic functioning in the substantia nigra of patients with schizophrenia, as well as reduced GABAergic inhibition, excessive glutamatergic excitation, and several other disturbances. These results highlight the importance of the substantia nigra in schizophrenia pathology and suggest that some aspects of molecular functioning in the substantia nigra could potentially be used as treatment targets or biomarkers.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2023)

Article Oncology

The patients' experience of neuroimaging of primary brain tumors: a cross-sectional survey study

Ivar J. H. G. Wamelink, Hugo L. L. Hempel, Elsmarieke van de Giessen, Mark H. M. Vries, Philip De Witt Hamer, Frederik Barkhof, Vera C. C. Keil

Summary: This study aims to understand the experiences of patients with primary brain tumors regarding MRI, follow-up protocols, and the use of gadolinium-based contrast agents (GBCAs). The analysis of patient surveys revealed that patients consistently underestimated the number of previous scans and most patients did not find MRI bothersome and would not change the frequency of follow-up MRIs. Women were found to be more uncomfortable with the MRI and receiving intravenous cannulas. Patient knowledge of GBCAs was limited.

JOURNAL OF NEURO-ONCOLOGY (2023)

Article Clinical Neurology

Redefinition of dementia care in Italy in the era of amyloid-lowering agents for the treatment of Alzheimer's disease: an expert opinion and practical guideline

Massimo Filippi, Giordano Cecchetti, Annachiara Cagnin, Camillo Marra, Flavio Nobili, Lucilla Parnetti, Federica Agosta

Summary: Currently, no disease-modifying therapies are available for Alzheimer's disease (AD) in Europe. However, evidence from clinical trials suggests that anti-beta amyloid (Aβ) monoclonal antibodies (mAbs) may be authorized for marketing in the near future. A group of prominent AD clinical experts in Italy met to discuss patient selection and management strategies, recognizing the need for significant changes in dementia care to implement disease-modifying therapies. They emphasized the importance of a biological diagnosis using amyloid- and tau-related biomarkers, as well as specialized diagnostic work-up and exclusion criteria assessment by neurology specialists. The experts also proposed a reorganization of dementia and cognitive decline centers into three levels with defined tasks and requirements.

JOURNAL OF NEUROLOGY (2023)

Review Medicine, General & Internal

Continuing Challenges in the Definitive Diagnosis of Cushing's Disease: A Structured Review Focusing on Molecular Imaging and a Proposal for Diagnostic Work-Up

Tessa N. A. Slagboom, Dirk Jan Stenvers, Elsmarieke van de Giessen, Stefan D. D. Roosendaal, Maartje M. L. de Win, Joseph C. J. Bot, Eleonora Aronica, Rene Post, Jantien Hoogmoed, Madeleine L. L. Drent, Alberto M. M. Pereira

Summary: The study provides a structured analysis of the diagnostic accuracy and clinical use of molecular imaging in patients with ACTH-dependent Cushing's syndrome, as well as the role of multidisciplinary counseling in decision making. It proposes a complementary diagnostic algorithm for both de novo and recurrent or persistent Cushing's disease. The use of molecular imaging modalities is of added and complementary value in the detection of pituitary microadenoma in ACTH-dependent Cushing's syndrome.

JOURNAL OF CLINICAL MEDICINE (2023)

Review Oncology

Head-To-Head Comparison of PET and Perfusion Weighted MRI Techniques to Distinguish Treatment Related Abnormalities from Tumor Progression in Glioma

Dylan Henssen, Lars Leijten, Frederick J. A. Meijer, Anja van der Kolk, Anne I. J. Arens, Mark ter Laan, Robert J. Smeenk, Anja Gijtenbeek, Elsmarieke M. van de Giessen, Nelleke Tolboom, Daniela E. Oprea-Lager, Marion Smits, James Nagarajah

Summary: Sophisticated imaging techniques have been suggested for distinguishing tumor progression (TP) from treatment-related abnormalities (TRA) in post-treatment surveillance of gliomas. However, it remains unclear if any technique holds diagnostic superiority. This meta-analysis compared the diagnostic accuracy of different imaging techniques and found no superior technique.

CANCERS (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Whole-liver flip-angle shimming at 7 T using parallel-transmit kT-point pulses and Fourier phase-encoded DREAM B1+ mapping

Bobby A. Runderkamp, Thomas Roos, Wietske van der Zwaag, Gustav J. Strijkers, Matthan W. A. Caan, Aart J. Nederveen

Summary: This study aimed to achieve homogeneous signal throughout the human liver at 7 T. By using subject-specific multichannel absolute B-1(+) maps and parallel-transmit k(T)-point pulses for flip angle (FA) shimming, homogeneous whole-liver images were obtained.

MAGNETIC RESONANCE IN MEDICINE (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Brain PET and SPECT imaging and quantification: a survey of the current status in the UK

Sofia K. Michopoulou, John C. Dickson, Glen G. Gardner, Thomas R. Gee, Andrew J. Fenwick, Timothy Melhuish, Clare A. Monaghan, Neil O'Brien, Angus M. J. Prosser, Catherine J. Scott, Roger T. Staff, Jonathan Taylor

Summary: This study evaluated the use of Brain SPECT and PET scans in the UK and explored drivers and barriers to using quantitative analysis through an online survey. The results showed variations across the UK, with high availability of DaTscan imaging and quantification and lower availability of other SPECT and PET scans.

NUCLEAR MEDICINE COMMUNICATIONS (2023)

Article Neurosciences

Solving large-scale MEG/EEG source localisation and functional connectivity problems simultaneously using state-space models

Jose Sanchez-Bornot, Roberto C. Sotero, J. A. Scott Kelso, Ozguer Simsek, Damien Coyle

Summary: This study proposes a multi-penalized state-space model for analyzing unobserved dynamics, using a data-driven regularization method. Novel algorithms are developed to solve the model, and a cross-validation method is introduced to evaluate regularization parameters. The effectiveness of this method is validated through simulations and real data analysis, enabling a more accurate exploration of cognitive brain functions.

NEUROIMAGE (2024)